Bousfiha, A. et al. Human inborn errors of immunity: 2019 update of the IUIS phenotypical classification. J. Clin. Immunol. 40, 66–81 (2020).
Article PubMed PubMed Central Google Scholar
Marmont, A., Peschle, C., Sanguineti, M. & Condorelli, M. Pure red cell aplasia (PRCA): response of three patients of cyclophosphamide and/or antilymphocyte globulin (ALG) and demonstration of two types of serum IgG inhibitors to erythropoiesis. Blood 45, 247–261 (1975).
Article CAS PubMed Google Scholar
Notarangelo, L. D., Bacchetta, R., Casanova, J. L. & Su, H. C. Human inborn errors of immunity: an expanding universe. Sci. Immunol. 5, eabb1662 (2020).
Article CAS PubMed PubMed Central Google Scholar
Agrawal, A. & Schatz, D. G. RAG1 and RAG2 form a stable postcleavage synaptic complex with DNA containing signal ends in V(D)J recombination. Cell 89, 43–53 (1997). A seminal paper showing that V(D)J recombination is mediated by RAG1 and RAG2.
Article CAS PubMed Google Scholar
Goodnow, C. C. et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334, 676–682 (1988).
Article CAS PubMed Google Scholar
Nguyen, K., Alsaati, N., Le Coz, C. & Romberg, N. Genetic obstacles to developing and tolerizing human B cells. WIREs Mech. Dis. 14, e1554 (2022).
Article CAS PubMed Google Scholar
Chen, C. et al. The site and stage of anti-DNA B-cell deletion. Nature 373, 252–255 (1995). This paper shows in an antibody gene knock-in mouse model that receptor editing is nearly complete and is focused on the light-chain rather than the heavy-chain locus.
Article CAS PubMed Google Scholar
Wardemann, H. et al. Predominant autoantibody production by early human B cell precursors. Science 301, 1374–1377 (2003). A landmark paper showing the high frequency of self-reactive and polyreactive BCRs in immature B cells escaping central tolerance.
Article CAS PubMed Google Scholar
Walter, J. E. et al. Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency. J. Clin. Invest. 125, 4135–4148 (2015). An important paper showing that ACAAs, particularly antibodies to type 1 interferons, are a feature of many human primary immunodeficiencies with autoimmunity and defective thymus function.
Article PubMed PubMed Central Google Scholar
Chen, J. W. et al. Positive and negative selection shape the human naive B cell repertoire. J. Clin. Invest. 132, e150985 (2022). Recent evidence in humans directly implicating regulatory T cells in the maintenance of peripheral B cell tolerance.
Article CAS PubMed PubMed Central Google Scholar
Sauer, A. V. et al. Defective B cell tolerance in adenosine deaminase deficiency is corrected by gene therapy. J. Clin. Invest. 122, 2141–2152 (2012).
Article CAS PubMed PubMed Central Google Scholar
Kinnunen, T. et al. Accumulation of peripheral autoreactive B cells in the absence of functional human regulatory T cells. Blood 121, 1595–1603 (2013).
Article CAS PubMed PubMed Central Google Scholar
Hervé, M. et al. CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance. J. Exp. Med. 204, 1583–1593 (2007).
Article PubMed PubMed Central Google Scholar
Sng, J. et al. AIRE expression controls the peripheral selection of autoreactive B cells. Sci. Immunol. 4, eaav6778 (2019).
Article CAS PubMed PubMed Central Google Scholar
Meyers, G. et al. Activation-induced cytidine deaminase (AID) is required for B-cell tolerance in humans. Proc. Natl Acad. Sci. USA 108, 11554–11559 (2011).
Article CAS PubMed PubMed Central Google Scholar
Leonardo, S. M., Josephson, J. A., Hartog, N. L. & Gauld, S. B. Altered B cell development and anergy in the absence of Foxp3. J. Immunol. 185, 2147–2156 (2010).
Article CAS PubMed Google Scholar
Meager, A. et al. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Med. 3, e289 (2006).
Article PubMed PubMed Central Google Scholar
Meloni, A. et al. Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I. J. Clin. Endocrinol. Metab. 93, 4389–4397 (2008).
Article CAS PubMed Google Scholar
Rosenberg, J. M. et al. Neutralizing anti-cytokine autoantibodies against interferon-α in immunodysregulation polyendocrinopathy enteropathy X-linked. Front. Immunol. 9, 544 (2018).
Article PubMed PubMed Central Google Scholar
Ferré, E. M. N., Schmitt, M. M. & Lionakis, M. S. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. Front. Pediatr. 9, 723532 (2021).
Article PubMed PubMed Central Google Scholar
Sharifinejad, N. et al. Clinical, immunological, and genetic features in 938 patients with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a systematic review. Expert Rev. Clin. Immunol. 17, 807–817 (2021).
Article CAS PubMed Google Scholar
Malchow, S. et al. Aire enforces immune tolerance by directing autoreactive T cells into the regulatory T cell lineage. Immunity 44, 1102–1113 (2016).
Article CAS PubMed PubMed Central Google Scholar
Besnard, M., Padonou, F., Provin, N., Giraud, M. & Guillonneau, C. AIRE deficiency, from preclinical models to human APECED disease. Dis. Model Mech. 14, dmm046359 (2021).
Article CAS PubMed PubMed Central Google Scholar
Puel, A. et al. Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J. Exp. Med. 207, 291–297 (2010). This paper shows that neutralizing autoantibodies targeting IL-17 and IL-22 in patients with APS1 represent phenocopies of patients with mutations in IL17F, IL17RA or IL17RC who present with mucocutaneous candidiasis.
Article CAS PubMed PubMed Central Google Scholar
Kisand, K. et al. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. J. Exp. Med. 207, 299–308 (2010).
Article CAS PubMed PubMed Central Google Scholar
Kärner, J. et al. IL-6-specific autoantibodies among APECED and thymoma patients. Immun. Inflamm. Dis. 4, 235–243 (2016).
Article PubMed PubMed Central Google Scholar
Meyer, S. et al. AIRE-deficient patients harbor unique high-affinity disease-ameliorating autoantibodies. Cell 166, 582–595 (2016).
Article CAS PubMed PubMed Central Google Scholar
Vazquez, S. E. et al. Identification of novel, clinically correlated autoantigens in the monogenic autoimmune syndrome APS1 by proteome-wide PhIP-Seq. eLife 9, e55053 (2020).
Article CAS PubMed PubMed Central Google Scholar
Petersen, A. et al. Cytokine-specific autoantibodies shape the gut microbiome in autoimmune polyendocrine syndrome type 1. J. Allergy Clin. Immunol. 148, 876–888 (2021).
Article CAS PubMed PubMed Central Google Scholar
Kärner, J. et al. Anti-cytokine autoantibodies suggest pathogenetic links with autoimmune regulator deficiency in humans and mice. Clin. Exp. Immunol. 171, 263–272 (2013).
Article PubMed PubMed Central Google Scholar
Sarkadi, A. K. et al. Autoantibodies to IL-17A may be correlated with the severity of mucocutaneous candidiasis in APECED patients. J. Clin. Immunol. 34, 181–193 (2014).
Article CAS PubMed Google Scholar
Bichele, R. et al. IL-22 neutralizing autoantibodies impair fungal clearance in murine oropharyngeal candidiasis model. Eur. J. Immunol. 48, 464–470 (2018).
Article CAS PubMed Google Scholar
Break, T. J. et al. Aberrant type 1 immunity drives susceptibility to mucosal fungal infections. Science 371, eaay5731 (2021).
Article CAS PubMed PubMed Central Google Scholar
Oikonomou, V., Break, T. J., Gaffen, S. L., Moutsopoulos, N. M. & Lionakis, M. S. Infections in the monogenic autoimmune syndrome APECED. Curr. Opin. Immunol. 72, 286–297 (2021).
Article CAS PubMed PubMed Central Google Scholar
Bastard, P. et al. Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1. J. Exp. Med. 218, e20210554 (2021).
留言 (0)